Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

NCT00020540 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Kidney Cancer
Melanoma (Skin)

Interventions

BIOLOGICAL: recombinant CD40-ligand
BIOLOGICAL: recombinant flt3 ligand

Sponsor

National Cancer Institute (NCI)